Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

PAHC Stock Annual Income Statement. Download in Excel

Phibro Animal Health Corporation logo

Phibro Animal Health Corporation

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

21.69
 
USD
  
-0.12
  
(-0.55%)
Previous close: 21.81  Open: 21.47  Bid: 20.89  Ask: 22.55
52 week range    
10.04   
   25.98
Mkt Cap: 905 M  Avg Vol (90 Days): 178,478
Peers   
HSKA / 
ADM / 
ZTS / 
ICCC / 
MRK / 
Last updated: Monday 23rd December 2024

Stock Rankings

58
MarketXLS Rank
80
Value
38
Technical
57
Quality
How are these ranks calculated?
Search for a stock

Financials

PAHC Income Statement

Annual
Jun-15Jun-16Jun-17Jun-18Jun-19Jun-20Jun-21Jun-22Jun-23Jun-24
Amortization of intangibles-5 M-6 M-6 M-6 M27 M53 M53 M53 M53 M55 M
Basic EPS from continuing operations1.350.831.341.210.810.06
Basic EPS total1.552.111.631.611.350.831.341.210.810.06
Basic weighted shares outstanding39 M39 M39524.040181.040412.040454.040473.041 M41 M41 M
Cost of sales-515 M-512 M-516 M-553 M563 M543 M562 M657 M680 M705 M
Depreciation-22 M-23 M-26 M-27 M28 M32 M32 M33 M34 M36 M
DepreciationAndAmortization-22 M-23 M-26 M-27 M28 M32 M32 M33 M34 M36 M
Diluted EPS total1.512.071.611.611.350.831.341.210.810.06
Diluted normalized net income/share1.350.831.341.210.810.06
Diluted weighted shares outstanding40 M40 M40042.040385.040523.040504.040504.041 M41 M41 M
Dividends paid per share0.40.40.40.40.460.480.480.480.48
Earnings from equity interest16 M16 M16 M-19 M-19 M-19 M
EarningsFromEquityInterestNetOfTax16 M16 M16 M-19 M-19 M-19 M
GainOnSaleOfBusiness-2 M
GainOnSaleOfSecurity1 M
GeneralAndAdministrativeExpense-7 M-8 M-8 M-33 M181 M188 M197 M206 M226 M260 M
Gross operating profit233 M239 M248 M267 M265 M257 M271 M285 M298 M313 M
ImpairmentOfCapitalAssets-2 M-2 M1 M1 M1 M1 M1 M1 M
Income before tax79 M77 M81 M88 M72 M56 M66 M72 M54 M11 M
Income restructuring and M&A-613000.0-1 M-1 M-1 M425000.0366000.0
Income taxes18 M-6 M16 M23 M17 M22 M12 M23 M21 M9 M
Interest income-249000.0256000.02 M2 M2 M2 M838000.0816000.0-15 M-19 M
InterestExpenseNonOperating-15 M-17 M-17 M-14 M12 M14 M12 M12 M58000.0462000.0
MiscOtherSpecialCharges-3 M820 M16 M-11 M
Net income from total operations60 M83 M65 M65 M55 M34 M54 M49 M33 M2 M
NetIncomeCommonStockholders60 M83 M65 M65 M55 M34 M54 M49 M33 M2 M
NetIncomeContinuousOperations60 M83 M65 M65 M55 M34 M54 M49 M33 M2 M
NetNonOperatingInterestIncomeExpense14 M17 M-15 M12 M-12 M-13 M-13 M-12 M-15 M-19 M
NetOperatingInterestIncomeExpense-14 M-17 M-15 M-12 M
NonRecurringOperationExpense-899000.0
Normalized income54 M13 M
Operating income88 M86 M98 M-721 M83 M69 M75 M79 M72 M53 M
Operating income before depreciation (EBITDA)87 M84 M91 M102 M112 M102 M110 M118 M106 M49 M
OperatingExpense146 M153 M150 M168 M181 M188 M197 M206 M226 M260 M
Other income net-521000.0-17 M3 M-820 M-18 M19 M264000.05 M3 M12 M
Other special charges-2 M
OtherGandA-7 M-8 M-8 M-33 M181 M188 M197 M206 M226 M260 M
OtherImpairmentOfCapitalAssets-2 M
OtherOperatingExpenses-3 M-8 M-1 M-2 M-6 M-11 M-2 M-5 M-2 M-2 M
OtherWriteOff226000.0-67000.0-96000.0-122000.0-2 M-428000.0264000.0180000.03 M2 M
RentAndLandingFees-7 M-8 M-8 M-8 M9 M
Research & development expense-10 M-11 M-9 M-10 M12 M14 M18 M21 M24 M29 M
ResearchExpense12 M14 M18 M21 M24 M29 M
RestructringAndMnAIncome-613000.0-1 M-1 M-1 M425000.0366000.0
Revenue per share-6 M-7 M-7 M-7 M28 M54 M54 M54 M54 M56 M
SalariesAndWages-4 M-4 M-2 M-334000.02 M-517000.0-1 M-1 M705000.011 M
Selling Gen & administrative expense146 M153 M150 M168 M181 M188 M197 M206 M226 M260 M
SellingAndMarketingExpense146 M153 M150 M168 M
SellingExpense146 M153 M150 M168 M
Special income/charges613000.01 M4 M3 M-1 M-1 M-1 M-1 M-1 M-903000.0
Total Income available for interest expense (EBIT)64 M60 M64 M74 M83 M69 M78 M84 M54 M11 M
Total common shares outstanding39 M39 M40 M40 M40 M40 M41 M41 M41 M41 M
Total net income60 M83 M65 M65 M55 M34 M54 M49 M33 M2 M
Total ordinary shares20 M20 M20 M20 M20 M20 M20 M20 M20 M20 M
Total revenues749 M752 M764 M820 M828 M800 M833 M942 M978 M1,018 M
TotalExpenses-370 M-359 M-366 M-385 M745 M731 M758 M863 M906 M964 M
TotalRevenue749 M752 M764 M820 M828 M800 M833 M942 M978 M1,018 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University